Abbott Laboratories v. Hospira Inc.
1:12-cv-00234
π‘ 5G SEP β’ ETSI DeclaredOverview
Parties
Defendant
Abbott Laboratories NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
Hospira Inc. Operating Company
Represented By
3 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Duane Morris LLP
1201 North Market Street, Suite 501
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Counter Defendant
Wisconsin Alumni Research Foundation NPE (University / Research)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 5,597,815 A Asserted | US Continuation / Sibling | View Official Patent → |
| π¨π¦ Canada | CA 002224284 A | Canada Counterpart | View Official Patent → |
| π¨π¦ Canada | CA 2224284 C | Canada Counterpart | View Official Patent → |
| π©πͺ Germany | DE 69634483 T | Germany Counterpart | View Official Patent → |
| π―π΅ Japan | JP 50595697 A | Japan Counterpart | View Official Patent → |
| π―π΅ Japan | JP 3255926 B2 | Japan Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 1997002826 A2 | PCT World Application | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 96,926,066 A | European Counterpart (EP) | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 837,681 B1 | European Counterpart (EP) | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP β’ ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5597815
Prevention of hyperphosphatemia in kidney disorder patients
|
Filed: 1995-07-13
Issued: 1997-01-28
|
Expired (Term Ended)
Expires: 2015-07-13
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
0
Motions by Category
Key Dispositive Motions & Rulings